Trial
NCT02827838
Durvalumab Before Surgery in Treating Patients With Oral Cavity or Oropharynx Cancer
Early Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Wake Forest University Health Sciences
Collaborators
National Cancer Institute (NCI)
Condition
Human Papillomavirus Infection
Intervention
Durvalumab
Why stopped
Study closed prior to meeting enrollment goal and funding issues
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-03-17